1. Home
  2. RNAZ vs CREV Comparison

RNAZ vs CREV Comparison

Compare RNAZ & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • CREV
  • Stock Information
  • Founded
  • RNAZ 2016
  • CREV 2007
  • Country
  • RNAZ United States
  • CREV Australia
  • Employees
  • RNAZ N/A
  • CREV N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • CREV
  • Sector
  • RNAZ Health Care
  • CREV
  • Exchange
  • RNAZ Nasdaq
  • CREV Nasdaq
  • Market Cap
  • RNAZ 8.7M
  • CREV 7.0M
  • IPO Year
  • RNAZ 2021
  • CREV N/A
  • Fundamental
  • Price
  • RNAZ $8.60
  • CREV $2.49
  • Analyst Decision
  • RNAZ Strong Buy
  • CREV
  • Analyst Count
  • RNAZ 1
  • CREV 0
  • Target Price
  • RNAZ $280.00
  • CREV N/A
  • AVG Volume (30 Days)
  • RNAZ 19.3K
  • CREV 118.8K
  • Earning Date
  • RNAZ 11-14-2025
  • CREV 01-01-0001
  • Dividend Yield
  • RNAZ N/A
  • CREV N/A
  • EPS Growth
  • RNAZ N/A
  • CREV N/A
  • EPS
  • RNAZ N/A
  • CREV N/A
  • Revenue
  • RNAZ N/A
  • CREV $47,677,475.00
  • Revenue This Year
  • RNAZ N/A
  • CREV $40.32
  • Revenue Next Year
  • RNAZ N/A
  • CREV N/A
  • P/E Ratio
  • RNAZ N/A
  • CREV N/A
  • Revenue Growth
  • RNAZ N/A
  • CREV 86.77
  • 52 Week Low
  • RNAZ $6.15
  • CREV $2.00
  • 52 Week High
  • RNAZ $468.44
  • CREV $12.75
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 34.45
  • CREV 33.10
  • Support Level
  • RNAZ $8.41
  • CREV $2.26
  • Resistance Level
  • RNAZ $9.85
  • CREV $4.58
  • Average True Range (ATR)
  • RNAZ 0.68
  • CREV 0.73
  • MACD
  • RNAZ -0.30
  • CREV -0.29
  • Stochastic Oscillator
  • RNAZ 11.05
  • CREV 9.24

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Share on Social Networks: